(Q37973439)

26 August 2017

title

Antiepileptic drug selection for people with HIV/AIDS: evidence-based guidelines from the ILAE and AAN. (English)

1 reference

26 August 2017

0 references

2

1 reference

26 August 2017

3

Emilio Perucca

1 reference

26 August 2017

7

Jason F Okulicz

1 reference

26 August 2017

Gretchen L Birbeck

1

1 reference

26 August 2017

David M Simpson

4

1 reference

26 August 2017

Henry Fraimow

5

1 reference

26 August 2017

Jomy M George

6

1 reference

26 August 2017

David B Clifford

8

1 reference

26 August 2017

Houda Hachad

9

1 reference

26 August 2017

René H Levy

10

1 reference

26 August 2017

Quality Standards Subcommittee Of The American Academy Of Neurology

11

1 reference

26 August 2017

Ad Hoc Task Force Of The Commission On Therapeutic Strategies Of The International League Against Epilepsy

12

1 reference

26 August 2017

publication date

1 January 2012

1 reference

26 August 2017

1 reference

26 August 2017

volume

53

1 reference

26 August 2017

issue

1

1 reference

26 August 2017

page(s)

207-214

1 reference

Lability of antiretroviral drug resistance mutations--correlates with immunological and virological responses

26 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2011.03335.X

Update on rifampin and rifabutin drug interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2011.03335.X

Carbamazepine toxicity induced by lopinavir/ritonavir and nelfinavir.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2011.03335.X

Clinically significant drug interaction between tipranavir-ritonavir and phenobarbital in an HIV-infected subject

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2011.03335.X

Increased incidence of peripheral neuropathy with co-administration of stavudine and isoniazid in HIV-infected individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2011.03335.X

Tuberculosis and HIV co-infection: a practical therapeutic approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2011.03335.X

The effect of atazanavir and atazanavir/ritonavir on UDP-glucuronosyltransferase using lamotrigine as a phenotypic probe

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2011.03335.X

Inhibitory effect of stiripentol on carbamazepine and saquinavir metabolism in human

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2011.03335.X

Duration and predictors of CD4 T-cell gains in patients who continue combination therapy despite detectable plasma viremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2011.03335.X

Effects of valproic acid coadministration on plasma efavirenz and lopinavir concentrations in human immunodeficiency virus-infected adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2011.03335.X

Effects of minocycline and valproic acid coadministration on atazanavir plasma concentrations in human immunodeficiency virus-infected adults receiving atazanavir-ritonavir.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2011.03335.X

Drug-drug interactions and tolerance in combining antituberculosis and antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2011.03335.X

Continued high prevalence and adverse clinical impact of human immunodeficiency virus-associated sensory neuropathy in the era of combination antiretroviral therapy: the CHARTER Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2011.03335.X

The spectrum of medical conditions and symptoms before acquired immunodeficiency syndrome in homosexual and bisexual men infected with the human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2011.03335.X

New-onset seizures associated with human immunodeficiency virus infection: causation and clinical features in 100 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2011.03335.X

A generalized seizure following initiation of nelfinavir in a patient with human immunodeficiency virus type 1 infection, suspected due to interaction between nelfinavir and phenytoin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2011.03335.X

Carbamazepine--indinavir interaction causes antiretroviral therapy failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2011.03335.X

Lack of a pharmacokinetic effect of raltegravir on midazolam: in vitro/in vivo correlation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2011.03335.X

Pharmacokinetic interaction between efavirenz and carbamazepine after multiple-dose administration in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2011.03335.X

Potential interaction between ritonavir and carbamazepine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2011.03335.X

Frequency of seizures and epilepsy in neurological HIV-infected patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2011.03335.X

Pharmacokinetic interaction between zidovudine and valproic acid in patients infected with human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2011.03335.X

Coadministration of lopinavir/ritonavir and phenytoin results in two-way drug interaction through cytochrome P-450 induction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2011.03335.X

Virological control during the first 6-18 months after initiating highly active antiretroviral therapy as a predictor for outcome in HIV-infected patients: a Danish, population-based, 6-year follow-up study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2011.03335.X

Ritonavir-induced carbamazepine toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2011.03335.X

Characterization of nelfinavir binding to plasma proteins and the lack of drug displacement interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2011.03335.X

Virologic outcomes of HAART with concurrent use of cytochrome P450 enzyme-inducing antiepileptics: a retrospective case control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2011.03335.X

Prognostic value of changes in CD4 count and HIV RNA during the first six months on highly active antiretroviral therapy in chronic human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2011.03335.X

Prospective study of new-onset seizures in patients with human immunodeficiency virus infection: etiologic and clinical aspects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2011.03335.X

A potentially significant interaction between efavirenz and phenytoin: a case report and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2011.03335.X

Reduced valproate plasma levels possible after introduction of efavirenz in a bipolar patient.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2011.03335.X

Possible interaction between lopinavir/ritonavir and valproic Acid exacerbates bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2011.03335.X

The effect of raltegravir on the glucuronidation of lamotrigine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2011.03335.X

Differential evolution of Human Immunodeficiency Virus type 1 Protease and Reverse Transcriptase genes between HAART-failing and naïve-treated individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2011.03335.X

Seizures in human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2011.03335.X

Antiretroviral Concentrations in Untimed Plasma Samples Predict Therapy Outcome in a Population with Advanced Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2011.03335.X

HIV neuropathy natural history cohort study: Assessment measures and risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2011.03335.X

10.1111/J.1528-1167.2011.03335.X

21 January 2018

Identifiers

DOI

1 reference

26 August 2017

1 reference